The Global Entry Of New Pharmaceuticals: A Joint Investigation Of Launch Window And Price
Research on the launch of new products in the international realm is scarce. The present paper is the first to document how launch window (difference in months between the first worldwide launch and the subsequent launch in a specific country) and launch price are interrelated and how regulation influences both launch window and launch price. The paper context is the global - 50 countries worldwide - launch of 58 new ethical drugs across 29 therapeutic areas. The authors show that the fastest launch occurs when the launch price is moderately high and the highest launch price occurs at a launch window of 85 months.